ArticleCancer research2024

HSF1 Inhibits Antitumor Immune Activity in Breast Cancer by Suppressing CCL5 to Block CD8+ T-cell Recruitment.

Curteisha Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.